Home Actavis revenue rises 60% to beat estimates
 

Keywords :   


Actavis revenue rises 60% to beat estimates

2015-05-11 14:21:50| Biotech - Topix.net

Actavis PLC said Monday that its revenue rose a better-than-expected 60% in the first quarter that included the acquisition of Botox maker Allergan Inc. Dublin-based Actavis completed its acquisition of Allergan in March, closing the biggest deal from 2014 and ending one of the year's more dramatic takeover battles. The deal made Actavis one of the world's largest drug makers by sales, offering a range of eye, skin and stomach drugs.

Tags: beat estimates revenue rises

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
01.07Boeing to get 'sweetheart deal' -victims' lawyer
01.07Tropical Storm Chris Graphics
01.07Hurricane Beryl Forecast Discussion Number 10
01.07Tropical Storm Chris Forecast Discussion Number 2
01.07Tropical Storm Chris Wind Speed Probabilities Number 2
01.07Tropical Storm Chris Public Advisory Number 2
01.07Summary for Tropical Storm Chris (AT3/AL032024)
01.07Tropical Storm Chris Forecast Advisory Number 2
More »